IL153853A0 - Bifunctional molecules and vectors complexed therewith for targeted gene delivery - Google Patents
Bifunctional molecules and vectors complexed therewith for targeted gene deliveryInfo
- Publication number
- IL153853A0 IL153853A0 IL15385301A IL15385301A IL153853A0 IL 153853 A0 IL153853 A0 IL 153853A0 IL 15385301 A IL15385301 A IL 15385301A IL 15385301 A IL15385301 A IL 15385301A IL 153853 A0 IL153853 A0 IL 153853A0
- Authority
- IL
- Israel
- Prior art keywords
- gene delivery
- targeted gene
- bifunctional molecules
- complexed therewith
- vectors complexed
- Prior art date
Links
- 230000001588 bifunctional effect Effects 0.000 title 1
- 238000001476 gene delivery Methods 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61301700A | 2000-07-10 | 2000-07-10 | |
PCT/EP2001/007878 WO2002004522A2 (en) | 2000-07-10 | 2001-07-09 | Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
IL153853A0 true IL153853A0 (en) | 2003-07-31 |
Family
ID=24455529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15385301A IL153853A0 (en) | 2000-07-10 | 2001-07-09 | Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1301541A2 (en) |
JP (1) | JP2004502450A (en) |
AU (1) | AU2001277531A1 (en) |
CA (1) | CA2414272A1 (en) |
IL (1) | IL153853A0 (en) |
WO (1) | WO2002004522A2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7232899B2 (en) | 1996-09-25 | 2007-06-19 | The Scripps Research Institute | Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
US7329728B1 (en) | 1999-10-25 | 2008-02-12 | The Scripps Research Institute | Ligand activated transcriptional regulator proteins |
US7217796B2 (en) | 2002-05-24 | 2007-05-15 | Schering Corporation | Neutralizing human anti-IGFR antibody |
CN1542132A (en) * | 2003-04-30 | 2004-11-03 | 上海新霁生物科技有限公司 | Highly expressed recombinant virus containing human constant region all-antibody gene and its use for treating tumor |
US7326567B2 (en) | 2003-11-12 | 2008-02-05 | Schering Corporation | Plasmid system for multigene expression |
PE20050928A1 (en) | 2003-11-21 | 2005-11-08 | Schering Corp | THERAPEUTIC COMBINATIONS OF ANTI-IGFR1 ANTIBODY |
JP2008521907A (en) | 2004-12-03 | 2008-06-26 | シェーリング コーポレイション | Biomarkers for preselecting patients for anti-IGF1R treatment |
EP1885385A2 (en) * | 2005-05-31 | 2008-02-13 | THURNHER, Martin Andreas | Phosphatidylinositol combination composition and 3'-phosphorylated lysophosphatidylinositols in the treatment of cancer and autoimmune diseases |
JP6017422B2 (en) | 2010-08-10 | 2016-11-02 | エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ(ウペエフエル)Ecole Polytechnique Federale de Lausanne (EPFL) | Erythrocyte binding therapy |
US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
CN106029874B (en) * | 2013-12-16 | 2020-09-15 | 北卡罗来纳-查佩尔山大学 | Depletion of plasmacytoid dendritic cells |
AU2015233084B2 (en) | 2014-02-21 | 2020-12-17 | Anokion Sa | Glycotargeting therapeutics |
US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
PL3126383T3 (en) | 2014-04-03 | 2019-08-30 | Igm Biosciences, Inc. | Modified j-chain |
SG10202001779UA (en) | 2015-01-20 | 2020-04-29 | Igm Biosciences Inc | Tumor necrosis factor (tnf) superfamily receptor binding molecules and uses thereof |
WO2017059380A1 (en) | 2015-09-30 | 2017-04-06 | Igm Biosciences, Inc. | Binding molecules with modified j-chain |
CN108463472A (en) | 2015-09-30 | 2018-08-28 | Igm生物科学有限公司 | The binding molecule of J- chains with modification |
CL2016000164A1 (en) * | 2016-01-21 | 2016-07-29 | Pontificia Universidad Católica De Chile | Monoclonal antibodies specific for the human adenovirus piii antigen (adv), produced and secreted by cellular hybridomas, useful for the detection and diagnosis of adv caused infection. |
WO2018232176A1 (en) | 2017-06-16 | 2018-12-20 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU742365B2 (en) * | 1997-03-14 | 2002-01-03 | Selective Genetics, Inc. | Adenoviral vectors with modified tropism |
DE19849643A1 (en) * | 1998-10-29 | 2000-05-04 | Deutsches Krebsforsch | Antibodies to the AAV capsid that change cell tropism and method for directed gene transfer |
-
2001
- 2001-07-09 EP EP01955340A patent/EP1301541A2/en not_active Withdrawn
- 2001-07-09 AU AU2001277531A patent/AU2001277531A1/en not_active Abandoned
- 2001-07-09 WO PCT/EP2001/007878 patent/WO2002004522A2/en not_active Application Discontinuation
- 2001-07-09 JP JP2002509384A patent/JP2004502450A/en active Pending
- 2001-07-09 CA CA002414272A patent/CA2414272A1/en not_active Abandoned
- 2001-07-09 IL IL15385301A patent/IL153853A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1301541A2 (en) | 2003-04-16 |
CA2414272A1 (en) | 2002-01-17 |
WO2002004522A3 (en) | 2002-07-18 |
WO2002004522A2 (en) | 2002-01-17 |
JP2004502450A (en) | 2004-01-29 |
AU2001277531A1 (en) | 2002-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL153853A0 (en) | Bifunctional molecules and vectors complexed therewith for targeted gene delivery | |
MXPA02012749A (en) | B7-like molecules and uses thereof. | |
HUP0202635A3 (en) | Targeting multimeric imaging agents through multilocus binding | |
HUS1300012I1 (en) | Soluble ctla4 mutant molecules and uses thereof | |
IL160001A0 (en) | Peptide based multimeric targeted contrast agents and methods for the preparation thereof | |
AU5711501A (en) | Improved water-insoluble drug particle process | |
AU5091201A (en) | Vegf-modulated genes and methods employing them | |
GB0012997D0 (en) | Gene delivery | |
AU7296801A (en) | Il-17 molecules and uses thereof | |
AU4196801A (en) | Chordin-like-2 molecules and uses thereof | |
EP1341497A4 (en) | Receptor antagonist-lipid conjugates and delivery vehicles containing same | |
IL155139A0 (en) | Targeting molecules for adenoviral vectors | |
EP1165597A4 (en) | Bifunctional molecules for delivery of therapeutics | |
AU4744201A (en) | Systemic gene delivery vehicles for the treatment of tumors | |
EP1147213A4 (en) | Novel rgs-containing molecules and uses thereof | |
IL128193A0 (en) | Rhamnosyl-transferase gene and uses thereof | |
AU2002356898A8 (en) | Gene amplification and overexpression in cancer | |
AU2002365188A8 (en) | Nucleic acid delivery and expression | |
IL153573A0 (en) | Clk-2, cek-7 and coq-4 genes, and uses thereof | |
IL145775A0 (en) | 13 transmembrane protein expressed in prostate cancer | |
EP1173192A4 (en) | Methods and compositions for targeted drug delivery | |
GB0107560D0 (en) | Improvements in travelling wave amplifiers | |
HUP0300813A3 (en) | Genes and proteins, and their uses | |
EP1229924A4 (en) | Targeted bifunctional molecules and therapies based thereon | |
AU5617200A (en) | Nodavirus-based dna expression vector and uses thereof |